CRISPR And Cas Genes Market Players: Lonza, Merck Kgaa, Takara Bio Inc., And Synthego

 CRISPR And Cas Genes Industry Overview

The global CRISPR and cas genes market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028. 2020 was a remarkable year for the market as the Nobel Prize in Chemistry was received by Emmanuelle Charpentier and Jennifer A. Doudna for the breakthrough research in CRISPR/Cas9 genetic scissors for genome editing, thereby positively impacting the market.

Furthermore, the development of CRISPR-based diagnostic tests to address the timeline and sample collection challenges for COVID-19 screening is driving the market. The tests are designed to offer advantages such as high precision and sensitivity, rapid detection, no requirement of special laboratory equipment, and portability. For instance, in December 2020, researchers from Gladstone Institutes developed a CRISPR-based test that uses smartphones to deliver results.


Gather more insights about the market drivers, restrains and growth of the Global CRISPR And Cas Genes market

Apart from this, the technological advancements in CRISPR/Cas9 system have revolutionized the area of cancer research and treatment. This has become the mainstream methodology used in many cancer biology studies. In addition, in March 2021, the U.S. FDA approved clinical trial testing for a CRISPR-based gene therapy product, designed to treat genetic defects resulting in sickle cell disease. This trial will be led by researchers from the University of California San Francisco and UC Berkeley.

Furthermore, competition among the existing players has increased owing to technological developments and their potential applications. There has been an increased focus on the highly adaptable CRISPR technology. For instance, as of May 2020, Merck KGaA has received a total of 26 CRISPR patents worldwide. This indicates the increasing focus of biotechnology companies on CRISPR/Cas gene technology.

The CRISPR and Cas gene-based genome editing applications are more or less in a nascent stage of development and a considerable number of possible usages are still unchartered. These areas can later be a source of the significant untapped potential provided that specific product-based commercialization picks up the pace that numerous investors in the market are anticipating.

 

Browse through Grand View Research's Biotechnology Industry Research Reports.

  • Spine Biologics Market - The global spine biologics market size was estimated at USD 1.8 billion in 2018 and is anticipated to expand at a CAGR of 4.2% over the forecast period. Increasing prevalence of degenerative spine disorders and a subsequent increase in treatment rates, advancements in bone grafting procedures, and high demand for minimally invasive procedures are some of the key contributing factors for market growth.

 

  • Biological Safety Testing Products & Services Market - The global biological safety testing products & services market size was valued at USD 2.77 billion in 2018 and is expected to grow at a CAGR of 12.3% over the forecast period. The market is primarily driven by the increasing production of new-generation biologics by major pharmaceutical and biotechnology companies. The high prevalence of target diseases globally has encouraged companies to increase the production of advanced biologics.

 

CRISPR And Cas Genes Market Segmentation

Grand View Research has segmented the global CRISPR and Cas genes market on the basis of product and service, application, end-use, and region:

CRISPR & Cas Genes Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

  • By Product
    • Kits & Enzymes
      • Vector-based Cas
      • DNA-free Cas
    • Libraries
    • Design Tool
    • Antibodies
    • Others
  • By Service
    • Cell Line Engineering
    • gRNA Design
    • Microbial Gene Editing
    • DNA Synthesis

 

CRISPR & Cas Genes Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Biomedical
    • Genome Engineering
    • Disease Model Studies
    • Functional Genomics
    • Epigenetics
    • Others
  • Agricultural

 

CRISPR & Cas Genes End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CROs)

 

CRISPR & Cas Genes Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • April 2021: CRISPR Therapeutics and Vertex Pharmaceuticals, Inc. amended their collaboration agreement for the development of a CRISPR/Cas9-based gene editing therapy - CTX001. This therapy can be used to treat transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD).

 

Key Companies profiled:

Some prominent players in the global CRISPR And Cas Genes market include

  • AstraZeneca plc.
  • Addgene
  • Caribou Biosciences, Inc.
  • Cellectis, CRISPR Therapeutics
  • Editas Medicine, Inc.
  • eGenesis
  • Hoffmann-La Roche Ltd.
  • Horizon Discovery Group plc
  • GenScript
  • Danaher Corporation
  • Intellia Therapeutics, Inc.
  • Lonza
  • Merck KGaA
  • Intellia Therapeutics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Synthego
  • Mammoth Biosciences
  • Inscripta, Inc.
  • Cibus
  • Beam Therapeutics
  • PLANTeDIT
  • Vertex Pharmaceuticals Incorporated
  • Hera BioLabs
  • OriGene Technologies, Inc.
  • Recombinetics, Inc.

 

Order a free sample PDF of the CRISPR And Cas Genes Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Dna-Based Skin Care Products Market: Offline Distribution Channel Led And Held A Revenue Share

  DNA-based Skin Care Products Industry Overview The global  DNA-based skin care products market  size is expected to reach USD 9.87 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. Consumer awareness of the dangers of using skincare products containing synthetic chemicals is pushing the demand for natural and organic products. Many DNA-based companies have been promoting awareness of DNA-based skincare products through digital and social media campaigns because today's consumers are tech-savvy and want products that are best suited to them.   Everyone's skin is different, so instead of a generic approach from over-the-counter items, consumers need a regimen that is tailored to their own needs. Consumers are now being targeted more directly by skincare specialists, who are prescribing a customized range of products. The Skin360 Face Scanner app from Neutrogena identifies over two...
Read more

Circulating Tumor Cells Market Players: BIOCEPT, Inc., Biocep Ltd., Ikonisys Inc., And Miltenyi Biotec

  Circulating Tumor Cells Industry Overview The global  circulating tumor cells market  size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.7% from 2021 to 2027. Many potential applications of CTCs in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products Research organizations are engaged in endeavors aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed.   Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and enable rapid recovery owing to their non-invasive nature. Moreover, it enables minimal invasive screening of tumors before opting for complex...
Read more

Flow Cytometry Market: Asia Pacific Is Projected To Exhibit Exponential Growth During The Forecast Period

  Flow Cytometry Industry Overview The global  flow cytometry market  size is expected to reach a value of USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2027. The high prevalence of chronic diseases, the introduction of technologically advanced flow cytometry solutions, and increasing R&D investments in the pharmaceutical industry are expected to propel market growth over the forecast period.   Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. Also, in January 2019, Beckman Coulter, a subsidiary of Danaher Corporation, expanded its clinical flow cytometry portfolio with the launch of its new ClearLLab 10C System. This newly la...
Read more